Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Reparixin

EU orphan designation number: EU/3/11/912   
Active ingredient: Reparixin
Indication: Prevention of graft rejection in pancreatic islet transplantation
Sponsor: Dompé farmaceutici s.p.a.
Via Santa Lucia 6, 20122 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/10/2011 Orphan Designation EMA/OD/049/11 (2011)7045 of 27/09/2011
23/03/2015 Transfer of orphan designation EMA/OD/049/11/T/01 (2015)2046 of 19/03/2015